The Joplin Globe’s editor, Carol Stark, now keeps a journal that she will use to document her experiences as she becomes a participant in a Phase II trial of ADI-PEG 20 in combination with Gemcitabine and Docetaxel for the treatment of software tissue sarcoma.  The...